<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
UROQUEST MEDICAL CORPORATION
(Exact Name of Registrant as Specified in its Charter)
DELAWARE 59-3176454
(State of Incorporation or Organization) (I.R.S.Employer Identification no.)
265 EAST 100 SOUTH, SUITE 220,
SALT LAKE CITY, UT 84111
(Address of principal executive offices) (zip code)
If this Form relates to the If this Form relates to the
registration of a class of registration of a class of
debt securities and is debt securities and is to
effective upon filing pursuant become effective
to General Instruction A(c)(1) simultaneously with the
please check the following effectiveness of a concurrent
box. \ \ registration statement under
the Securities Act of 1933
pursuant to General
Instruction A(c)(2) please
check the following box. \ \
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to Name of Each Exchange on Which
be so Registered Each Class is to be Registered
None
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK, PAR VALUE $.001
(Title of class)
<PAGE> 2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Common Stock to be registered hereunder is
contained in the section entitled:Description of Capital Stock," commencing at
page 59 of the Prospectus included in the Registrant's Form S-1 Registration
Statement, No. 333-07277, filed with the Securities and Exchange Commission (the
"Commission:) on June 28, 1996. The description of the section entitled
"Description of Capital Stock" appearing in the Registrant's final prospectus
filed pursuant to Rule 424 (b) is incorporated herein by reference.
EXHIBIT
NUMBER DESCRIPTION
1.1 Specimen certificate for Registrant's Common Stock(1)
2.1 Restated Certificate of Incorporation of the
Registrant.(1)
3.1 Bylaws of the Registrant.(1)
- ----------------------------
(1) Filed as exhibit to Registrant's Form S-1 Registration Statement, No.
333-07277, filed with the Securities and Exchange Commission on June
28, 1996 and incorporated herein by reference.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has caused this registration statement
to be signed on its behalf by the undersigned, thereto duly authorized.
UROQUEST MEDICAL CORPORATION
(REGISTRANT)
Date: July 2, 1996 By: /s/ G. S. Ayers
---------------------------------------
Gregory S. Ayers
Vice President, Chief Financial Officer
